Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...

Nature’s Miracle Holding, Inc. Announces Up to $29.7 Million Financing

ONTARIO, Calif., Jan. 13, 2025 /PRNewswire/ -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services...

China Liberal Education Holdings Limited Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency

BEIJING, Jan. 13, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ: CLEU), a China-based company that provides technological consulting services...

Yiwu Brands Unite for Overseas Expansion with Grand Opening of Yiwu Selection Store

YIWU, China, Jan. 13, 2025 /PRNewswire/ -- Yiwu, the world's preeminent hub for small commodities, hosts an extensive trading network connecting the globe with...
1...4,3114,3124,313Page 4,313 of 4,313